FMA
IMMU

FNY Managed Accounts’s Immunomedics Inc IMMU Stock Holding History

FNY Managed Accounts’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-204
Closed -$3K – 923
2017
Q4 		$3K Sell
204
-196
-49% -$2.31K ﹤0.01% 489
2017
Q3 		$5K Buy
+400
New +$3.99K 0.01% 532
2016
Q2 		– Sell
-25,000
Closed -$62.5K – 458
2016
Q1 		$62.5K Buy
+25,000
New +$56.2K 0.11% 129

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

FNY Managed Accounts's IMMU Position: Q1 2018 in Review

FNY Managed Accounts sold out of Immunomedics Inc (IMMU) in Q1 2018, closing a stake of 204 shares — an estimated $3K sold.

FNY Managed Accounts first reported a position in IMMU in Q1 2016 and held it in 3 quarters. The position peaked at $62.5K in Q1 2016. 168 funds tracked by Wall St. Rank hold IMMU as of Q1 2018.

  • FNY Managed Accounts reported no remaining Immunomedics Inc position as of Q1 2018 after selling out during the quarter.
  • FNY Managed Accounts sold 204 Immunomedics Inc shares in Q1 2018, an estimated $3K.
  • FNY Managed Accounts first reported a position in Immunomedics Inc in Q1 2016 and held it in 3 quarters.
  • FNY Managed Accounts's Immunomedics Inc position peaked at $62.5K in Q1 2016.
  • 168 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.